(Q34365119)

1 August 2017

Clinical implications of shared genetics and pathogenesis in autoimmune diseases (English)

1 reference

1 August 2017

3

1 reference

1 August 2017

Alexandra Zhernakova

1

0 references

author name string

Sebo Withoff

series ordinal

2

1 reference

PubMed ID

23959365

1 August 2017

language of work or name

1 reference

20 August 2013

1 reference

Nature Reviews Endocrinology

1 August 2017

1 reference

1 August 2017

9

1 reference

1 August 2017

11

1 reference

1 August 2017

646-659

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.161

1 August 2017

0 references

cites work

The adaptive immune response in celiac disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Cellular immune responses in autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Emerging patterns of genetic overlap across autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Detecting shared pathogenesis from the shared genetics of immune-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Pleiotropy in complex traits: challenges and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Seven newly identified loci for autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Shared and distinct genetic variants in type 1 diabetes and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Psoriasis and autoimmune disorders: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A coding variant in NLRP1 is associated with autoimmune Addison's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

An integrated encyclopedia of DNA elements in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association identifies multiple ulcerative colitis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Clinical significance of complement deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Links between complement abnormalities and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Epidemiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Polyglandular autoimmune syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Evaluation of coverage variation of SNP chips for genome-wide association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Environmental triggers of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Anti-inflammatory therapy in chronic disease: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

TNF receptor 2 pathway: drug target for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Defining the role of the MHC in autoimmunity: a review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genetics and the impact on treatment protocols in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

NF-kappa B as a therapeutic target in autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Targeting IL-17 and TH17 cells in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Coinhibitory molecules in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A genome-wide association study identifies two new risk loci for Graves' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Multiple common variants for celiac disease influencing immune gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genetic susceptibility to SLE: recent progress from GWAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Recent advances in the genetics of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The genetics of type I interferon in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Averting inflammation by targeting the cytokine environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Immune development and intestinal microbiota in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

An iceberg of childhood coeliac disease in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Type 1 diabetes: translating mechanistic observations into effective clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The microRNA spectrum in 12 body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs and potential target interactions in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Circulating microRNA is a biomarker of pediatric Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs in immune response and macrophage polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Noncanonical microRNAs and endogenous siRNAs in normal and psoriatic human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Circulating microRNA expression profiles associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Metabolic changes in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Are patients with potential celiac disease really potential? The answer of metabonomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Metabolic disturbances associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Role of the gut microbiota in immunity and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Microbiome dynamics of human epidermis following skin barrier disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genes, environment and the value of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Genetics, pathogenesis and clinical interventions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Shared familial aggregation of susceptibility to autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Multiple loci in the HLA complex are associated with Addison's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

The role of a nonsynonymous CD226 (DNAX-accessory molecule-1) variant (Gly 307Ser) in isolated Addison’s disease and autoimmune polyendocrinopathy type 2 pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Mapping of immune-mediated disease genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Autoimmune Addison's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Rheumatoid arthritis is linked to oral bacteria: etiological association.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

(1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

A profile of volatile organic compounds in breath discriminates COPD patients from controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.161

Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease

31 March 2020

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

Novel biological treatments for systemic lupus erythematosus: current and future modalities.

1 reference

12 December 2020

Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients

1 reference

12 December 2020

Metabolomics of volatile organic compounds in cystic fibrosis patients and controls

1 reference

12 December 2020

Does the gut microbiota trigger Hashimoto's thyroiditis?

1 reference

12 December 2020

The PreventCD Study design: towards new strategies for the prevention of coeliac disease.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.161

1 reference

PubMed ID

23959365

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

23959365